CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges [0.03%]
嵌合抗原受体T细胞治疗胃肠肿瘤：临床试验及应对挑战的策略
Hinrich Abken
Hinrich Abken
Despite multimodal treatment options, most gastrointestinal cancers are still associated with high mortality rates and poor responsiveness to immunotherapy. The unprecedented efficacy of chimeric antigen receptor (CAR)-engineered T cells in...
Zhonghan Sun,Yan Zheng
Zhonghan Sun
East Asian populations, which account for approximately 20% of the global population, have become central to the worldwide rise of metabolic diseases over the past few decades. The prevalence of metabolic disorders, including type 2 diabete...
Eleni Kotsiliti
Eleni Kotsiliti
International collaborative research to improve gallbladder cancer prevention [0.03%]
国际协作研究改善胆囊癌预防措施
Dominique Scherer,Rajiv Kumar,Justo Lorenzo Bermejo;EULAT Eradicate GBC
Dominique Scherer
Reply to 'Incorporating genetic variations in alcohol-associated liver disease trials for East Asian populations' [0.03%]
《在东亚人群酒精相关肝病试验中纳入遗传变异的回应》
Mack C Mitchell,Brian P Lee,Jessica Mellinger et al.
Mack C Mitchell et al.
M Carmen Ortuño-Costela,Massimo Pinzani,Ludovic Vallier
M Carmen Ortuño-Costela
The liver fulfils a plethora of vital functions and, due to their importance, liver dysfunction has life-threatening consequences. Liver disorders currently account for more than two million deaths annually worldwide and can be classified b...
Jordan Hindson
Jordan Hindson